Physician profile
Christopher W King
NPI 1427347483
$828.29
in general payments reported to CMS, 2019-2025
10 companies · $96.54 in 2025
The $96.54 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2021: $17.30 · 2022: $199 · 2023: $87.04 · 2024: $177 · 2025: $96.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $277.65 | 2023-2025 | Lifevest |
| Inari Medical, INC. | $198.99 | 2022 | |
| Mylan Specialty L.P. | $109.67 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $90.21 | 2019 | |
| Ucb, INC. | $33.47 | 2019 | |
| Octapharma USA, INC. | $30.90 | 2024 | Balfaxar |
| Merck Sharp & Dohme LLC | $27.74 | 2025 | Zerbaxa |
| Abbott Laboratories | $24.07 | 2024 | Jot Dx |
| Allergan, INC. | $18.29 | 2019 | |
| Chiesi USA, INC. | $17.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.